Compare ACHC & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACHC | NEOG |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2011 | 1995 |
| Metric | ACHC | NEOG |
|---|---|---|
| Price | $33.80 | $10.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 4 |
| Target Price | ★ $22.67 | $10.67 |
| AVG Volume (30 Days) | ★ 3.2M | 1.9M |
| Earning Date | 04-29-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.05 | 0.02 |
| Revenue | ★ $3,312,769,000.00 | $894,661,000.00 |
| Revenue This Year | $5.08 | N/A |
| Revenue Next Year | $5.98 | N/A |
| P/E Ratio | $672.00 | ★ $518.75 |
| Revenue Growth | ★ 5.04 | N/A |
| 52 Week Low | $11.43 | $4.56 |
| 52 Week High | $34.02 | $11.43 |
| Indicator | ACHC | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 71.12 | 64.62 |
| Support Level | $22.52 | $8.82 |
| Resistance Level | N/A | $10.30 |
| Average True Range (ATR) | 1.69 | 0.41 |
| MACD | 0.28 | 0.09 |
| Stochastic Oscillator | 91.30 | 89.40 |
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.